All updated as on -
Forecasts indicate that the worldwide market for hemostasis products will reach a value of $1.59 billion in 2024 and will exceed $2.68 billion by 2031. Forecasts indicate that the market will expand at a CAGR of 7.3% from 2018 to 2023.
Several alternative methods exist for achieving hemostasis in medical procedures and surgeries when the body is unable or unable to perform it on its own. Shock and stress make hemostasis more difficult to obtain. Various methods, both chemical and mechanical or physical, can be used to stop bleeding. As an alternative to conventional surgical methods, the use of tissue adhesives and topical hemostatic agents (physical agents, biologically active agents) is employed to control bleeding from surgical sites. Those cases involving sensitive tissues and patients with hemostatic problems, as well as diffuse non-anatomic bleeding, are where they really shine.
Hemostasis solutions are becoming increasingly popular as a means to guarantee the safety and success of patients undergoing cardiac-related surgeries, treatments, and other medical procedures. This trend is expected to propel the sector forward. An effective method to control bleeding during cardiac surgeries is in high demand due to the rising incidence of cardiovascular disorders. The market for hemostasis products is being driven by a rising pool of cardiac patients, which is being exacerbated by an aging population and hazardous lifestyle patterns. nearly 17.6 million people die each year from cardiovascular disease, and that number is projected to rise to nearly 23.6 million by 2031, according to data compiled by the American Heart Association. More and more money is going into research and development to make products better and safer and easier to use.
A number of globally active sectors were negatively affected by the COVID-19 pandemic, which in turn reduced demand for hemostasis products. Precautionary lockdowns and the strict regulations imposed by governing bodies worldwide were the primary causes of the significant interruptions in their supply-chain operations and production. Moreover, there is a rising trend of customers aiming to reduce unnecessary expenditure.
With an emphasis on worldwide market trends, the "Hemostasis Products Market Analysis to 2028" provides a comprehensive and expert examination of the healthcare sector. The purpose of this research is to offer a synopsis of the hemostasis products market with comprehensive product, application, and end user segmentation data. Over the next few years, the hemostasis products industry is predicted to experience significant expansion. This research gives essential data on the current state of the market for hemostasis products, as well as important trends and opportunities in the industry.
Modified chitosan dressings, intranasal splints for sinus and nasal surgeries, and hemostatic foams are just a few examples of the recent inventions that have been very beneficial to the business. Microfibrillar collagen hemostats have recently become quite popular due to their ability to provide rapid hemostasis and positive patient outcomes, among other reported benefits. The company's growth will be propelled by the increasing need for technologically advanced hemostasis products. One example is the OEM hemostasis diagnostic equipment supplied by Siemens Healthcare Diagnostics Inc. to Sysmex Corporation, which was formalized in May 2024 through a worldwide OEM agreement.
Using qualitative and quantitative data, the research paints a comprehensive picture of the market. Various segments of the Hemostasis products market are included in the overview and forecast. In addition, the report breaks down the market by region, offering forecasts for each of the five most important areas from 2019 to 2028: North America, Europe, Asia-Pacific (APAC), MEA, and South and Central America. Subsegmentation of the global market for hemostasis products is carried out according to specific nations and segments. The research delves into the present trend and potential prospects in the region, as well as an analysis and prediction of 18 countries worldwide.
Report Coverage
Global Hemostasis Products research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Hemostasis Products report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Hemostasis Products competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Hemostasis Products market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Hemostasis Products market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Hemostasis Products market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Johnson & Johnson, Pfizer, Baxter International, Medtronic, B. Braun Melsungen AG, Becton, Dickinson and Company (BD), Tricol Biomedical, Hemostasis LLC, CuraMedical BV, Teleflex Incorporated.
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Hemostasis Products market based on the below-mentioned segments:
Global Hemostasis Products Market, By Product
Topical hemostasis products
Infusible hemostasis products
Advanced hemostasis products
Global Hemostasis Products market, By Application
Trauma
Surgery
Hemophilia
Myocardial infarction
Others
Global Hemostasis Products Market, By End User
Hospitals
Ambulatory surgery centers
Others
Global Hemostasis Products market, Regional Analysis
Several alternative methods exist for achieving hemostasis in medical procedures and surgeries when the body is unable or unable to perform it on its own. Shock and stress make hemostasis more difficult to obtain. Various methods, both chemical and mechanical or physical, can be used to stop bleeding. As an alternative to conventional surgical methods, the use of tissue adhesives and topical hemostatic agents (physical agents, biologically active agents) is employed to control bleeding from surgical sites. Those cases involving sensitive tissues and patients with hemostatic problems, as well as diffuse non-anatomic bleeding, are where they really shine.
Hemostasis solutions are becoming increasingly popular as a means to guarantee the safety and success of patients undergoing cardiac-related surgeries, treatments, and other medical procedures. This trend is expected to propel the sector forward. An effective method to control bleeding during cardiac surgeries is in high demand due to the rising incidence of cardiovascular disorders. The market for hemostasis products is being driven by a rising pool of cardiac patients, which is being exacerbated by an aging population and hazardous lifestyle patterns. nearly 17.6 million people die each year from cardiovascular disease, and that number is projected to rise to nearly 23.6 million by 2031, according to data compiled by the American Heart Association. More and more money is going into research and development to make products better and safer and easier to use.
A number of globally active sectors were negatively affected by the COVID-19 pandemic, which in turn reduced demand for hemostasis products. Precautionary lockdowns and the strict regulations imposed by governing bodies worldwide were the primary causes of the significant interruptions in their supply-chain operations and production. Moreover, there is a rising trend of customers aiming to reduce unnecessary expenditure.
With an emphasis on worldwide market trends, the "Hemostasis Products Market Analysis to 2028" provides a comprehensive and expert examination of the healthcare sector. The purpose of this research is to offer a synopsis of the hemostasis products market with comprehensive product, application, and end user segmentation data. Over the next few years, the hemostasis products industry is predicted to experience significant expansion. This research gives essential data on the current state of the market for hemostasis products, as well as important trends and opportunities in the industry.
Modified chitosan dressings, intranasal splints for sinus and nasal surgeries, and hemostatic foams are just a few examples of the recent inventions that have been very beneficial to the business. Microfibrillar collagen hemostats have recently become quite popular due to their ability to provide rapid hemostasis and positive patient outcomes, among other reported benefits. The company's growth will be propelled by the increasing need for technologically advanced hemostasis products. One example is the OEM hemostasis diagnostic equipment supplied by Siemens Healthcare Diagnostics Inc. to Sysmex Corporation, which was formalized in May 2024 through a worldwide OEM agreement.
Using qualitative and quantitative data, the research paints a comprehensive picture of the market. Various segments of the Hemostasis products market are included in the overview and forecast. In addition, the report breaks down the market by region, offering forecasts for each of the five most important areas from 2019 to 2028: North America, Europe, Asia-Pacific (APAC), MEA, and South and Central America. Subsegmentation of the global market for hemostasis products is carried out according to specific nations and segments. The research delves into the present trend and potential prospects in the region, as well as an analysis and prediction of 18 countries worldwide.
Report Coverage
Global Hemostasis Products research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Hemostasis Products report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Hemostasis Products competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Hemostasis Products market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2031 |
| Base Year | 2023 |
| Forecast Period | 2023-2031 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Johnson & Johnson, Pfizer, Baxter International, Medtronic, B. Braun Melsungen AG, Becton, Dickinson and Company (BD), Tricol Biomedical, Hemostasis LLC, CuraMedical BV, Teleflex Incorporated. |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Hemostasis Products Market from 2021 to 2031.
- Market Forecast for Hemostasis Products Market from 2021 to 2031.
- Regional Market Share and Revenue from 2021 to 2031.
- Country Market share within region from 2021 to 2031.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Hemostasis Products competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Hemostasis Products
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Hemostasis Products market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Hemostasis Products market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Johnson & Johnson, Pfizer, Baxter International, Medtronic, B. Braun Melsungen AG, Becton, Dickinson and Company (BD), Tricol Biomedical, Hemostasis LLC, CuraMedical BV, Teleflex Incorporated.
Primary Target Market
- Market Players of Hemostasis Products
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Hemostasis Products market based on the below-mentioned segments:
Global Hemostasis Products Market, By Product
Topical hemostasis products
Infusible hemostasis products
Advanced hemostasis products
Global Hemostasis Products market, By Application
Trauma
Surgery
Hemophilia
Myocardial infarction
Others
Global Hemostasis Products Market, By End User
Hospitals
Ambulatory surgery centers
Others
Global Hemostasis Products market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive hemostasis products market market research and competitor analysis for your business to help you develop more profound insights into the hemostasis products market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the hemostasis products market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.